Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Glycyrrhizic acid may help reduce unwanted hair growth.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Upadacitinib improved multiple immune-related conditions in one patient.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

JAK inhibitors show promise for treating various skin diseases.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Hairless protein can block vitamin D activation in skin cells.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

ITK inhibitors may effectively treat alopecia areata.

Farudodstat may effectively treat alopecia areata without harming hair follicles.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Cyproterone acetate temporarily reduces hair growth in women with idiopathic hirsutism but doesn't change hormone levels.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.